Prestige Consumer Healthcare Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was USD 1,125.36 million compared to USD 1,127.73 million a year ago. Net income was USD 209.34 million compared to net loss of USD 82.31 million a year ago. Basic earnings per share from continuing operations was USD 4.21 compared to basic loss per share from continuing operations of USD 1.65 a year ago. Diluted earnings per share from continuing operations was USD 4.17 compared to diluted loss per share from continuing operations of USD 1.65 a year ago.